A van Erkelens1, A S Sie1, P Manders2, A Visser3, L E Duijm4, R M Mann5, M Ten Voorde6, H Kroeze6, J B Prins3, N Hoogerbrugge7. 1. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 2. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Biobank, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Department of Medical Psychology, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Radiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. 5. Department of Radiology, Radboud University Medical Center, Nijmegen, The Netherlands. 6. Organization for Cancer Screening in the Eastern Region of the Netherlands, Zutphen, The Netherlands. 7. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: nicoline.hoogerbrugge@radboudumc.nl.
Abstract
INTRODUCTION: Identifying high familial breast cancer (FBC) risk improves detection of yet unknown BRCA1/2-mutation carriers, for whom BC risk is both highly likely and potentially preventable. We assessed whether a new online self-test could identify women at high FBC risk in population-based BC screening without inducing anxiety or distress. METHODS: After their visit for screening mammography, women were invited by email to take an online self-test for identifying highly increased FBC risk-based on Dutch guidelines. Exclusion criteria were previously diagnosed as increased FBC risk or a personal history of BC. Anxiety (State-Trait Anxiety Inventory Dutch Version), distress (Hospital Anxiety Depression Scale) and BC risk perception were assessed using questionnaires, which were completed immediately before and after taking the online self-test and 2 weeks later. RESULTS: Of the 562 women invited by email, 406 (72%) completed the online self-test while 304 also completed questionnaires (response rate 54%). After exclusion criteria, 287 (51%) were included for data analysis. Median age was 56 years (range 50-74). A high or moderate FBC risk was identified in 12 (4%) and three (1%) women, respectively. After completion of the online self-test, anxiety and BC risk perception were decreased while distress scores remained unchanged. Levels were below clinical relevance. Most women (85%) would recommend the self-test; few (3%) would not. CONCLUSION: The online self-test identified previously unknown women at high FBC risk (4%), who may carry a BRCA1/2-mutation, without inducing anxiety or distress. We therefore recommend offering this self-test to women who attend population-based screening mammography for the first time.
INTRODUCTION: Identifying high familial breast cancer (FBC) risk improves detection of yet unknown BRCA1/2-mutation carriers, for whom BC risk is both highly likely and potentially preventable. We assessed whether a new online self-test could identify women at high FBC risk in population-based BC screening without inducing anxiety or distress. METHODS: After their visit for screening mammography, women were invited by email to take an online self-test for identifying highly increased FBC risk-based on Dutch guidelines. Exclusion criteria were previously diagnosed as increased FBC risk or a personal history of BC. Anxiety (State-Trait Anxiety Inventory Dutch Version), distress (Hospital Anxiety Depression Scale) and BC risk perception were assessed using questionnaires, which were completed immediately before and after taking the online self-test and 2 weeks later. RESULTS: Of the 562 women invited by email, 406 (72%) completed the online self-test while 304 also completed questionnaires (response rate 54%). After exclusion criteria, 287 (51%) were included for data analysis. Median age was 56 years (range 50-74). A high or moderate FBC risk was identified in 12 (4%) and three (1%) women, respectively. After completion of the online self-test, anxiety and BC risk perception were decreased while distress scores remained unchanged. Levels were below clinical relevance. Most women (85%) would recommend the self-test; few (3%) would not. CONCLUSION: The online self-test identified previously unknown women at high FBC risk (4%), who may carry a BRCA1/2-mutation, without inducing anxiety or distress. We therefore recommend offering this self-test to women who attend population-based screening mammography for the first time.
Authors: Max Bayne; Madi Fairey; Barbora Silarova; Simon J Griffin; Stephen J Sharp; William M P Klein; Stephen Sutton; Juliet A Usher-Smith Journal: Patient Educ Couns Date: 2019-08-11
Authors: Nadeem Qureshi; Brittany Dutton; Stephen Weng; Christina Sheehan; Wendy Chorley; John F R Robertson; Denise Kendrick; Joe Kai Journal: Fam Cancer Date: 2020-06-11 Impact factor: 2.375
Authors: Ash Kieran Clift; David Dodwell; Simon Lord; Stavros Petrou; Sir Michael Brady; Gary S Collins; Julia Hippisley-Cox Journal: Br J Cancer Date: 2021-10-26 Impact factor: 9.075